Immunoglobulin signature predicts risk of post-acute COVID-19 syndrome.

导出 OA

翻译打印收藏纠错

第一作者： Carlo,Cervia

第一单位： Department of Immunology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.

作者： Carlo,Cervia ^[1] ; Yves,Zurbuchen ^[1] ; Patrick,Taeschler ^[1] ; Tala,Ballouz ^[2] ; Dominik,Menges ^[2] ; Sara,Hasler ^[1] ; Sarah,Adamo ^[1] ; Miro E,Raeber ^[1] ; Esther,Bächli ^[3] ; Alain,Rudiger ^[4] ; Melina,Stüssi-Helbling ^[5] ; Lars C,Huber ^[5] ; Jakob,Nilsson ^[1] ; Ulrike,Held ^[2] ; Milo A,Puhan ^[2] ; Onur,Boyman ^[6]

作者单位： Department of Immunology, University Hospital Zurich, University of Zurich, Zurich, Switzerland. ^[1] Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland. ^[2] Clinic for Internal Medicine, Uster Hospital, Uster, Switzerland. ^[3] Department of Medicine, Limmattal Hospital, Schlieren, Switzerland. ^[4] Clinic for Internal Medicine, City Hospital Triemli Zurich, Zurich, Switzerland. ^[5] Department of Immunology, University Hospital Zurich, University of Zurich, Zurich, Switzerland. onur.boyman@uzh.ch. ^[6] Faculty of Medicine, University of Zurich, Zurich, Switzerland. onur.boyman@uzh.ch. ^[7]